Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor-CD3 complex (TCR-CD3 complex), historically referred to as the T3 complex, is a multi-subunit transmembrane assembly essential for the adaptive immune system (StatPearls, 2023). It consists of the antigen-binding T-cell receptor (TCR) heterodimer non-covalently associated with the invariant CD3 signaling modules, which include the gamma, delta, and two epsilon chains, along with a zeta-chain homodimer (UniProt, 2024). When the TCR recognizes a specific peptide-MHC complex, the CD3 subunits transduce the signal into the T cell via immunoreceptor tyrosine-based activation motifs (ITAMs), leading to T-cell proliferation and effector function (PubMed, 2021). This complex is a critical therapeutic target for managing organ transplant rejection and autoimmune disorders like Type 1 diabetes, where monoclonal antibodies like Teplizumab are used to modulate or deplete T-cell populations (NIH, 2022). Additionally, it is a cornerstone of modern cancer immunotherapy through bispecific T-cell engagers (BiTEs) that bridge CD3 on T cells to tumor-associated antigens to induce targeted cytotoxicity (Wikipedia, 2024). The structural integrity and signaling capacity of the TCR-CD3 complex are vital for immune surveillance, and its dysregulation is implicated in various autoimmune and lymphoproliferative disorders.
Binding to the CD3 epsilon subunit to induce T-cell depletion, TCR internalization, or T-cell redirection to target cells
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor-CD3 complex (TCR-CD3 complex) (TCR-CD3 complex).